Literature DB >> 15344632

Allergic reaction to intranasal midazolam HCl: a case report.

Michael McIlwain1, Robert Primosch, Enrique Bimstein.   

Abstract

An acute allergic reaction in a 5-year-old healthy male, after receiving midazolam by intranasal atomizer for sedation purposes in the dental clinic, was reported. Shortly after the midazolam was provided, the child developed urticaria in both ankles, which rapidly progressed to the lower extremities, stomach, back, arms, neck, and face. The periorbital skin also became edematous. In the emergency room, the diagnosis of an urticaria allergic reaction was confirmed. The child was treated with intramuscular diphenylhydramine, discharged from the emergency room after 5 hours, and prescribed oral diphenylhydramine (Benadryl) and prednisolone (Orapred). Children who receive sedatives such as midazolam in the dental clinic should be carefully monitored from the moment they receive the sedative, in order to disclose and treat undesirable side effects of the sedative agents as early as possible. The implications of allergic reactions to sedative agents in the dental clinic are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344632

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  3 in total

1.  Anaphylactoid-like Reaction to Midazolam During Oral and Maxillofacial Surgery.

Authors:  Terumi Ayuse; Shinji Kurata; Takao Ayuse
Journal:  Anesth Prog       Date:  2015

2.  Innocent unilateral facial swelling after endoscopic sphincterotomy.

Authors:  Panagiotis Katsinelos; Stergios Gkagkalis; Kostas Fasoulas; Grigoris Chatzimavroudis; Christos Zavos; Jannis Kountouras
Journal:  Ann Gastroenterol       Date:  2013

3.  Hypersensitivity reaction to midazolam: a case of cardio-respiratory failure.

Authors:  Eleonora Nucera; Arianna Aruanno; Alessandro Buonomo; Giuseppe Parrinello; Angela Rizzi
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.